why choose us

First received: November 04, 2022

Clinical Trial: Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-small Cell Lung Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Locally Advanced Lung Non-Small Cell Carcinoma

Study Type: INTERVENTIONAL


Official Title: Phase III Prospective Randomized Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed by Concurrent Mediastinal Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer

Brief Summary: This phase III trial compares the effect of adding stereotactic body radiation therapy (SBRT) to standard treatment (image guided radiation therapy [IGRT] and chemotherapy followed by immunotherapy with durvalumab) versus standard treatment alone in treating patients with non-small cell lung cancer that cannot be treated by surgery (inoperable).SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision.This method may kill tumor cells with fewer doses over a shorter…

Read more